The BCR-Abl gene is associated with a dysregulation of TK function, subsequently leading to a malignant transformation in chronic myelogenous leukemia (CML) (18,19). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.